Prevalence of Epstein-Barr virus in oral squamous cell carcinoma

J Pathol. 1999 Sep;189(1):34-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<34::AID-PATH391>3.0.CO;2-4.

Abstract

Forty-six samples of oral squamous cell carcinoma (OSCC) were evaluated for the prevalence of Epstein-Barr virus (EBV) infection by the polymerase chain reaction (PCR), Southern blot hybridization, and in situ hybridization (ISH). EBV DNA was detected in 7 (15.2 per cent) out of 46 samples by a combination of PCR and Southern blot hybridization methods. All seven positive samples showed well-differentiated carcinoma, thus suggesting a possible relationship between EBV infection and the degree of differentiation of carcinoma tissue. Latent infection membrane protein 1 (LMP1) was detected immunohistochemically in six of the EBV-positive OSCCs. However, no signal of the EBV-encoded small RNA (EBER)-1 was demonstrated by the ISH method. No significant relationship was observed between EBV infection and lymph node metastasis. A follow-up study (range from 4.4 to 79 months; mean 34.9 months) showed no recurrence or death to occur in the EBV-positive patients, which thus suggested a good prognosis for EBV-positive OSCC patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Blotting, Southern
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / virology*
  • Cheek
  • Chi-Square Distribution
  • DNA, Viral / analysis*
  • Female
  • Follow-Up Studies
  • Gingival Neoplasms / pathology
  • Gingival Neoplasms / virology
  • Herpesvirus 4, Human / genetics*
  • Humans
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Mouth Floor
  • Mouth Mucosa
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / virology*
  • Palatal Neoplasms / pathology
  • Palatal Neoplasms / virology
  • Polymerase Chain Reaction
  • Prevalence
  • Prognosis
  • RNA, Viral / analysis
  • Tongue Neoplasms / pathology
  • Tongue Neoplasms / virology
  • Viral Matrix Proteins / analysis

Substances

  • DNA, Viral
  • EBV-associated membrane antigen, Epstein-Barr virus
  • Epstein-Barr virus encoded RNA 1
  • RNA, Viral
  • Viral Matrix Proteins